Clinitech Laboratory Ltd — Quarterly Results & Earnings

₹35.00

-6.23%

Profit Growth YoY36.36%Latest quarter

Sales Growth YoY24.51%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+36.36%

🔥 Exceptional growth

YoY Sales Growth+24.51%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

15.92%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

10.14

ROE

5.49%

ROCE

8.15%

💡

Growth Analysis

Clinitech Laboratory Ltd reported YoY profit growth of 36.36% and revenue growth of 24.51% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Clinitech Laboratory Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Service Provider Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.